CANbridge Pharmaceuticals Inc. has appointed Marcelo Cheresky to the position of Senior Vice President, Rare Disease Commercial Operations, effective as of July 16, 2019.   Mr. Cheresky has nearly 20 years’ business leadership experience in the biotechnology industry. Most recently, he was Vice President, Emerging Markets at Bioverativ, a Sanofi company, in Boston, MA, where he established regional structures for emerging markets and oversaw country launches in multiple emerging markets,...